|
Alfred B. "Roc" Ordman (born October 25, 1948) is an American biochemist and researcher into aging, life extension and the effects of free radicals on the body. He is Professor Emeritus of Chemistry and Biochemistry at Beloit College, Beloit, Wisconsin. He was a visiting Professor of Biochemistry, Rush Medical College, a private university in Chicago, Illinois. He has recommended that adults get 500 mg of Vitamin C twice per day to achieve the highest level that can be maintained in the blood serum. This is a level far above official recommendations and for which he now holds patents . His study published in 2006 demonstrated how a combination of 500 mg of vitamin C taken twice a day and 400 IU of vitamin E once a day protects a person from many forms of damage from free radicals . Another study he conducted used a process known as nutrient signaling to develop a nutraceutical treatment that may cause weight loss. The process uses signals from supplements of branched chain amino acids, oleic acid, and DHA (a component of fish oil) to signal the brain and adipose tissue to cause weight loss. A double-blind clinical trial in a 2-week pilot study was consistent with the hypothesis this may facilitate weight reduction in people. The peer-reviewed article was published in the Journal of the American Aging Association in 2008. Since retiring, he is involved in two studies. 1) To prevent the recurrence of superficial bladder carcinoma, which is the major form of bladder cancer. He conducted a clinical trial at Beloit College to determine the oral dosage of vitamin C that creates the highest concentration of vitamin C in the bladder. That concentration is high enough to kill cancer cells. This was published in the Journal of Cancer Therapy in 2015. This ongoing research was presented at the Linus Pauling Institute in 2013 . 2) Another trial he is conducting may reduce the level of protein misfolding, which may be the fourth cause of human aging . In the Teaberry Trial , volunteers consume blueberries followed by a cup of green tea. The combination elevates and sustains the level of EGCG in the serum, which is likely to reduce the level of errors when mRNA is translated. This research was presented at the Linus Pauling Institute in 2015.
|
|
|